Benzylpiperazine: the New Zealand legal perspective

Authors

  • T. Bassindale

    Corresponding author
    1. Institute of Environmental Science and Research Ltd, Kenepuru Science Centre, 34 Kenepuru Drive, Porirua, New Zealand
    • Institute of Environmental Science and Research Ltd, Kenepuru Science Centre, 34 Kenepuru Drive, Porirua, New Zealand.
    Search for more papers by this author

Abstract

In 2005 the New Zealand Government created a new schedule of ‘Restricted Substances’ under the Misuse of Drugs Act (1975). Benzylpiperazine was the first drug to be classified as what became known informally as ‘Class D’. The rationale behind that decision and the subsequent reclassification of benzylpiperazine to Class C, in 2008, is discussed.

Ancillary